Abstract
scFvs have considerable therapeutic potential against antigens (Ags) involved in disease processes (1 ,2), either as proteins synthesized ex vivo for passive administration, or introduced by gene therapy for in vivo expression. Their small size confers many pharmacological advantages, compared to whole antibodies (Abs). However, they lack intrinsic biological activity because they lack the Fc (effector) portion of native (whole) Abs. Biological activity can be imparted to scFvs by generating bifunctional molecules, in which the scFv that specifically recognizes an Ag on the target cells is genetically fused to an effector molecule. Examples include cytokines (3 ,4) or prodrug-converting enzymes (1 ,5,6). Alternatively, the effector molecule can be a second scFv that retargets the molecules toward a cell population, e.g., for activation of cytotoxic T cells (7) or for gene therapy, e.g., targeting recombinant adenoviruses carrying therapeutic genes (8).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Haisma, H. J., Sernee, M. F., Hooijberg, E., Brakenhoff, R. H., Meulen-Muileman, I. H., Pinedo, H. M., and Boven, E. (1998) Construction and characterization of a fusion protein of single-chain anti-CD20 antibody and human beta-glucuronidase for antibody-directed enzyme prodrug therapy. Blood 92, 184–190.
Yokota, R., Milenic, D. E., Whitlow, M., and Schlom, J. (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52, 3402–3408.
Savage, P., So A., Spooner, R. A., and Epenetos, A. A. (1993) A recombinant single chain antibody interleukin-2 fusion protein. Br. J. Cancer 67, 304–310.
Whittington, H. A., Ashworth, L. J., and Hawkins, R. E. (1998) Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins. Gene Ther. 5, 770–777.
Haisma, H. J., Brakenhoff, R. H., van der Meulen-Muileman, I., Pinedo, H. M., and Boven, E. (1998) Construction and characterization of a fusion protein of single-chain anti-carcinoma antibody 323/A3 and human beta-glucuronidase. Cancer Immunol. Immunother. 45, 266–272.
Helfrich, W., Haisma, H. J., Magdolen, V., Luther, T., Bom, V. J., Westra, J., et al. (2000) A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functions. J. Immunol. Methods b, 131–145.
Holliger, P. and Winter, G. (1993) Engineering bispecific antibodies. Curr. Opin. Biotechnol. 4, 446–449.
Haisma, H. J., Grill, J., Curiel, D. T., Hoogeland, S., van Beusechem, V. W., Pinedo, H. M., and Gerritsen, W. R. (2000) Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther. 7, 901–904.
Mullen, C. A., Kilstrup, M., and Blaese, R. M. (1992) Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl Acad. Sci. USA 89, 33–37.
Chan, S., Gabra, H., Hill, F., Evan, G., and Sikora, K. (1987) Novel tumour marker related to the c-myc oncogene product. Mol. Cell Probes 1, 73–82.
Hoogenboom, H. R., Griffiths, A. D., Johnson, K. S., Chiswell, D. J., Hudson, P. J., and Winter G. (1991) Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19, 4133–4137.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc.
About this protocol
Cite this protocol
de Graaf, M., van der Meulen-Muileman, I.H., Pinedo, H.M., Haisma, H.J. (2002). 34 Expression of scFvs and scFv Fusion Proteins in Eukaryotic Cells. In: O’Brien, P.M., Aitken, R. (eds) Antibody Phage Display. Methods in Molecular Biology™, vol 178. Humana Press. https://doi.org/10.1385/1-59259-240-6:379
Download citation
DOI: https://doi.org/10.1385/1-59259-240-6:379
Publisher Name: Humana Press
Print ISBN: 978-0-89603-906-3
Online ISBN: 978-1-59259-240-1
eBook Packages: Springer Protocols